Skip to main content
. 2019 Aug 9;11(8):1143. doi: 10.3390/cancers11081143

Figure 4.

Figure 4

SETDB1’s influence on epithelial-to-mesenchymal transition (EMT) programs that initiate metastasis. This metabolic reprogramming altered the breast cancer phenotype and contributed to progression through acquisition of cancer stem cell characteristics.